These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10896079)

  • 1. Refractory enteric amebiasis in pediatric patients with acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perret C; Harris PR; Rivera M; Vial P; Duarte I; Barriga F
    J Pediatr Gastroenterol Nutr; 2000 Jul; 31(1):86-90. PubMed ID: 10896079
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal amoebiasis in a patient with acute graft-versus-host disease after allogeneic bone marrow transplantation successfully treated by metronidazole.
    Numata A; Itabashi M; Kishimoto K; Motohashi K; Hagihara M; Kuwabara H; Tanaka M; Kato H; Chiba S; Kunisaki R; Fujisawa S
    Transpl Infect Dis; 2015 Dec; 17(6):886-9. PubMed ID: 26426525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation in children with ANL: Italian experience. AIEOP Group and the GITMO.
    Dini G; Abla O; Uderzo C; Polchi P; Locatelli F; Di Bartolomeo P; Arcese W; Messina C; Bandini G; Andolina M
    Bone Marrow Transplant; 1991; 7 Suppl 3():76-7. PubMed ID: 1855094
    [No Abstract]   [Full Text] [Related]  

  • 4. Allogeneic and autologous bone marrow transplantation in AML.
    Santos GW
    Leukemia; 1992; 6 Suppl 2():102-3. PubMed ID: 1578906
    [No Abstract]   [Full Text] [Related]  

  • 5. Amebiasis after bone marrow transplantation.
    Bavaro P; Di Girolamo G; Di Bartolomeo P; Angrilli F; Olioso P; Papalinetti G; Del Vecchio A; Torlontano G
    Bone Marrow Transplant; 1994 Feb; 13(2):213-4. PubMed ID: 8205092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How do allogeneic bone marrow transplants cure leukaemia? The role of graft versus host disease.
    Powles R; Treleaven J; Millar J; Gordon-Smith EC; Tiley C; Findlay M; Teo C; Duncombe A; Robinson G
    Bone Marrow Transplant; 1991; 7 Suppl 2():9-10. PubMed ID: 1878737
    [No Abstract]   [Full Text] [Related]  

  • 7. [Rejection of allogeneic bone marrow transplant. Case report].
    Szczylik C; Ratajczak M; Dumański Z; Myc A; Siekierzyński M; Rybicki Z; Kłos M; Zaboklicki S; Zaborowski P; Nowakowska B
    Pol Arch Med Wewn; 1988 Jan; 79(1):30-7. PubMed ID: 3275168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexplained effusions: association with allogeneic bone marrow transplantation and acute or chronic graft-versus-host disease.
    Pretnar J; Cernelc P; Mlakar U; Fortuna M
    Bone Marrow Transplant; 1996 Oct; 18(4):826. PubMed ID: 8899209
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of immunotherapy in the treatment of acute myeloblastic leukemia: from allogeneic bone marrow transplantation to the application of interleukin 2.
    Prentice HG; Macdonald ID; Hamon MD
    Cancer Treat Res; 1993; 64():121-34. PubMed ID: 8095790
    [No Abstract]   [Full Text] [Related]  

  • 10. Concomitant infection with Entamoeba histolytica and two Shigella strains.
    Gregory RL; Keller GC; Felsenfeld O
    South Med J; 1973 Dec; 66(12):1426-8. PubMed ID: 4357317
    [No Abstract]   [Full Text] [Related]  

  • 11. Disseminated zygomycosis post allogeneic bone marrow transplantation.
    Kannan K; Ur-Rehman J; Rao TV; Jain R; Dennison D
    Am J Hematol; 2005 May; 79(1):68-9. PubMed ID: 15849768
    [No Abstract]   [Full Text] [Related]  

  • 12. Low incidence of acute graft versus host disease in Thai patients after allogeneic bone marrow transplantation.
    Jootar S; Intragumtornchai T; Chuncharunee S; Seksan P; Hathirat P
    Transplant Proc; 1994 Aug; 26(4):2354-6. PubMed ID: 8066773
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunopotentiation with Ubenimex for prevention of leukemia relapse after allogeneic BMT. The Study Group of Ubenimex for BMT.
    Hiraoka A; Shibata H; Masaoka T
    Transplant Proc; 1992 Dec; 24(6):3047-8. PubMed ID: 1466051
    [No Abstract]   [Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for acute leukemia.
    Forman SJ; Blume KG
    Hematol Oncol Clin North Am; 1990 Jun; 4(3):517-33. PubMed ID: 2193012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
    Marco de F; Infante B; Giovanni S; Gesualdo L
    Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow transplantation for leukaemia: the role of total body irradiation, graft vs host disease, and haemopoietic chimerism.
    Bacigalupo A; Frassoni F; Van Lint MT; Titale V; Scarpati D; Occhini D; Gualandi F; Lamparelli T; Marmont AM
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():85. PubMed ID: 2697412
    [No Abstract]   [Full Text] [Related]  

  • 17. Association of malnutrition with amebiasis.
    Petri WA; Mondal D; Peterson KM; Duggal P; Haque R
    Nutr Rev; 2009 Nov; 67 Suppl 2():S207-15. PubMed ID: 19906225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Perreault C; Gyger M; Boileau J; Bonny Y; Cousineau S; Lacombe M; Lavallee R; Tawil E; D'Angelo G
    Can Med Assoc J; 1983 Nov; 129(9):969-74. PubMed ID: 6367917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
    Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
    Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic BMT for AML in Zagreb.
    Labar B; Bogdanić V; Nemet D; Mrsić M; Pavletić Z; Zupancić S; Radman I; Aurer I
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():86-7. PubMed ID: 2697413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.